Vimarsana
Biggest News Aggregation in the World

Harmonization Guideline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harmonization Guideline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harmonization Guideline Today - Breaking & Trending Today

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial | Infectious Diseases | JAMA - Vimarsana News

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial | Infectious Diseases | JAMA

This randomized clinical trial compares the efficacy and safety of letermovir vs valganciclovir prophylaxis for cytomegalovirus (CMV) disease in CMV-seronegativ